These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 27047655
1. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures. Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR. Skelet Muscle; 2016; 6():14. PubMed ID: 27047655 [Abstract] [Full Text] [Related]
2. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. Nghiem PP, Hoffman EP, Mittal P, Brown KJ, Schatzberg SJ, Ghimbovschi S, Wang Z, Kornegay JN. Am J Pathol; 2013 Nov; 183(5):1411-24. PubMed ID: 24160322 [Abstract] [Full Text] [Related]
3. Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease. Cotten SW, Kornegay JN, Bogan DJ, Wadosky KM, Patterson C, Willis MS. Am J Transl Res; 2013 Nov; 6(1):43-53. PubMed ID: 24349620 [Abstract] [Full Text] [Related]
7. Microvessel density in muscles of dogs with golden retriever muscular dystrophy. Nguyen F, Guigand L, Goubault-Leroux I, Wyers M, Cherel Y. Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137 [Abstract] [Full Text] [Related]
8. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Fakhfakh R, Michaud A, Tremblay JP. Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111 [Abstract] [Full Text] [Related]
14. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype. Stoughton WB, Li J, Balog-Alvarez C, Kornegay JN. Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363 [Abstract] [Full Text] [Related]
15. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle. Martin PT, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, Varki A, Flanigan KM, Kornegay JN. PLoS One; 2014 Sep; 9(2):e88226. PubMed ID: 24505439 [Abstract] [Full Text] [Related]
16. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Li J, Nghiem P, Detwiler DA, Larsen CA, Grange RW, Bhavaraju-Sanka RK, Tou S, Keene BP, Howard JF, Wang J, Fan Z, Schatzberg SJ, Styner MA, Flanigan KM, Xiao X, Hoffman EP. Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699 [Abstract] [Full Text] [Related]
20. Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy. Fan Z, Wang J, Ahn M, Shiloh-Malawsky Y, Chahin N, Elmore S, Bagnell CR, Wilber K, An H, Lin W, Zhu H, Styner M, Kornegay JN. Neuromuscul Disord; 2014 Feb; 24(2):178-91. PubMed ID: 24295811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]